Methylmalonic acidemia: genes and variants
Explore variant evidence for Methylmalonic acidemia across 3 analyzed proteins (MMUT, MMAB, MMAA). Linked ClinVar records include 40 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 5 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Methylmalonic acidemia
MMUT: Methylmalonyl-CoA mutase, mitochondrial
It converts methylmalonyl-CoA to succinyl-CoA in mitochondria using adenosylcobalamin as a cofactor. Biallelic loss-of-function variants cause isolated methylmalonic acidemia, which can lead to metabolic acidosis, hyperammonemia, neurologic injury, and chronic kidney disease.
33 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in MMUT have source records linked to Methylmalonic acidemia. Association strength is not clinical gene validity.
MMAB: Corrinoid adenosyltransferase MMAB
A mitochondrial enzyme that converts cobalamin into adenosylcobalamin, the cofactor used by methylmalonyl-CoA mutase. Variants cause the cblB form of methylmalonic acidemia.
4 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in MMAB have source records linked to Methylmalonic acidemia. Association strength is not clinical gene validity.
MMAA: Methylmalonic aciduria type A protein, mitochondrial
A mitochondrial GTPase that helps deliver and reactivate vitamin B12 cofactor for methylmalonyl-CoA mutase. Variants cause the cblA form of methylmalonic acidemia.
3 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in MMAA have source records linked to Methylmalonic acidemia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Methylmalonic acidemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MMAB R186Q | 186 | Pathogenic / likely pathogenic (★★) | |
| MMAB R186W | 186 | Pathogenic / likely pathogenic (★★) | |
| MMAB R190G | 190 | Pathogenic / likely pathogenic (★★) | |
| MMAB R190H | 190 | Pathogenic / likely pathogenic (★★) | |
| MMUT R369C | 369 | Pathogenic / likely pathogenic (★★) | |
| MMUT R369H | 369 | Pathogenic / likely pathogenic (★★) | |
| MMUT Y100C | 100 | Pathogenic / likely pathogenic (★★) | |
| MMUT A141E | 141 | Pathogenic / likely pathogenic (★★) | |
| MMUT G145S | 145 | Pathogenic / likely pathogenic (★★) | |
| MMUT T230R | 230 | Pathogenic / likely pathogenic (★★) | |
| MMUT S262N | 262 | Pathogenic / likely pathogenic (★★) | |
| MMUT L305S | 305 | Pathogenic / likely pathogenic (★★) | |
| MMUT L328F | 328 | Pathogenic / likely pathogenic (★★) | |
| MMUT L358P | 358 | Pathogenic / likely pathogenic (★★) | |
| MMUT R616C | 616 | B12-binding | Pathogenic / likely pathogenic (★★) |
| MMAA R145Q | 145 | Pathogenic / likely pathogenic (★★) | |
| MMAA V220M | 220 | Pathogenic / likely pathogenic (★★) | |
| MMUT R93H | 93 | Pathogenic / likely pathogenic (★★) | |
| MMUT G94V | 94 | Pathogenic / likely pathogenic (★★) | |
| MMUT R108H | 108 | Pathogenic / likely pathogenic (★★) | |
| MMUT A191E | 191 | Pathogenic / likely pathogenic (★★) | |
| MMUT N219Y | 219 | Pathogenic / likely pathogenic (★★) | |
| MMUT Y316C | 316 | Pathogenic / likely pathogenic (★★) | |
| MMUT N388K | 388 | Pathogenic / likely pathogenic (★★) | |
| MMUT G426R | 426 | Pathogenic / likely pathogenic (★★) | |
| MMUT G427D | 427 | Pathogenic / likely pathogenic (★★) | |
| MMUT E432A | 432 | Pathogenic / likely pathogenic (★★) | |
| MMUT G623R | 623 | B12-binding | Pathogenic / likely pathogenic (★★) |
| MMUT G630E | 630 | B12-binding | Pathogenic / likely pathogenic (★★) |
| MMUT G717V | 717 | B12-binding | Pathogenic / likely pathogenic (★★) |
| MMAA D258N | 258 | Pathogenic / likely pathogenic (★★) | |
| MMUT G203R | 203 | Pathogenic / likely pathogenic (★★) | |
| MMUT L674F | 674 | B12-binding | Pathogenic / likely pathogenic (★★) |
| MMUT A137G | 137 | Pathogenic / likely pathogenic (★★) | |
| MMUT I200T | 200 | Pathogenic / likely pathogenic (★★) | |
| MMUT A555T | 555 | Pathogenic / likely pathogenic (★★) | |
| MMUT R629G | 629 | B12-binding | Pathogenic / likely pathogenic (★★) |
| MMUT R694W | 694 | B12-binding | Pathogenic / likely pathogenic (★★) |
| MMUT H678R | 678 | B12-binding | Pathogenic / likely pathogenic (★) |
| MMUT G703R | 703 | B12-binding | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Methylmalonic acidemia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| MMUT R616H | 616 | B12-binding | Conflicting reports (★) | +7: in a 3D region that tolerates change poorly (4R); R616C at the same position is pathogenic; seen in 6.8e-06 of gnomAD DNA copies; REVEL 0.957 |
Which prediction tools work for Methylmalonic acidemia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- SIFT: 94 out of 100
- CADD: 93 out of 100
- phyloP: 86 out of 100
- Pangolin: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 31 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency also has ClinVar records linked to MMUT variants; they fall partly in the same places as the Methylmalonic acidemia variants (55 pathogenic / likely pathogenic).
- Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency also has ClinVar records linked to MMUT variants; they fall partly in the same places as the Methylmalonic acidemia variants (53 pathogenic / likely pathogenic).
- Methylmalonic aciduria cblb type also has ClinVar records linked to MMAB variants; they fall partly in the same places as the Methylmalonic acidemia variants (23 pathogenic / likely pathogenic).
- Methylmalonic aciduria, cblA type also has ClinVar records linked to MMAA variants; they fall mostly in different places as the Methylmalonic acidemia variants (21 pathogenic / likely pathogenic).
Diseases related to Methylmalonic acidemia
- Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, also linked to MMUT
- Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency, also linked to MMUT
- Methylmalonic aciduria cblb type, also linked to MMAB
- Methylmalonic aciduria, cblA type, also linked to MMAA
- Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, also linked to MMUT
- Likely inborn error of metabolism, also linked to MMUT
Frequently asked questions
Which genes have records linked to Methylmalonic acidemia?
This view contains 3 analyzed proteins: MMUT, MMAB, MMAA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 40 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 5 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 61 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center